Authors

  • Botirjon Zokirov
    Department of Hospital Pediatrics, Andijan State Medical Institute

DOI:

https://doi.org/10.71337/inlibrary.uz.ijms.136122

Keywords:

bronchial asthma children state program healthcare policy prevention early diagnosis Uzbekistan primary healthcare.

Abstract

Introduction: Childhood bronchial asthma represents a significant and growing public health challenge in Uzbekistan, contributing to substantial morbidity and socioeconomic burden. Delays in diagnosis and suboptimal prevention strategies at the primary healthcare level exacerbate the problem. A coordinated, state-level strategic approach is essential for effective long-term control. This article analyzes the strategic importance of national programs for the prevention and early detection of childhood asthma in Uzbekistan. Methods: This study employs a health policy analysis framework. It involves a systematic review of international guidelines from the World Health Organization (WHO) and the Global Initiative for Asthma (GINA), an analysis of successful national asthma programs in other countries, and an examination of Uzbekistan's current healthcare priorities as outlined in the "New Uzbekistan" Development Strategy for 2022-2026. A strategic framework was synthesized based on these data sources to identify key intervention areas for a national program. Results: The analysis identified two core strategic pillars for a comprehensive national program: (1) Primary Prevention and (2) Early Detection and Management. The Primary Prevention pillar encompasses three key domains: strengthening environmental controls to reduce exposure to pollutants and allergens; launching national public health campaigns to improve health literacy regarding asthma risk factors; and promoting healthy nutrition, including breastfeeding. The Early Detection pillar focuses on four critical areas: enhancing the capacity of primary healthcare professionals through continuous medical education; expanding access to objective diagnostic tools like spirometry in primary care settings; implementing a national screening program for high-risk children; and integrating digital health technologies and clinical decision support systems to standardize care. Conclusion: A comprehensive, government-led national program is critical to fundamentally improving childhood asthma outcomes in Uzbekistan. Such a program, built on the pillars of robust primary prevention and systematic early detection, has the potential to reduce the incidence and severity of the disease, decrease long-term healthcare costs, and improve the quality of life for millions of children. Successful implementation will require strong political commitment, multi-sectoral collaboration, and sustained financial investment.

background image

INTERNATIONAL JOURNAL

OF MEDICAL SCIENCES

ISSN NUMBER: 2692 - 5206

Volume 5,September ,2025

50

UDC: 616.248-053.2-036.22-07:614.2:005.6(575.1)

THE IMPORTANCE OF STATE PROGRAMS FOR THE PREVENTION AND EARLY

DETECTION OF CHILDHOOD BRONCHIAL ASTHMA IN UZBEKISTAN: A

STRATEGIC FRAMEWORK

Zokirov Botirjon Qobiljon ugli

Department of Hospital Pediatrics,

Andijan State Medical Institute

Abstract:

Introduction: Childhood bronchial asthma represents a significant and growing public

health challenge in Uzbekistan, contributing to substantial morbidity and socioeconomic burden.

Delays in diagnosis and suboptimal prevention strategies at the primary healthcare level

exacerbate the problem. A coordinated, state-level strategic approach is essential for effective

long-term control. This article analyzes the strategic importance of national programs for the

prevention and early detection of childhood asthma in Uzbekistan. Methods: This study employs

a health policy analysis framework. It involves a systematic review of international guidelines

from the World Health Organization (WHO) and the Global Initiative for Asthma (GINA), an

analysis of successful national asthma programs in other countries, and an examination of

Uzbekistan's current healthcare priorities as outlined in the "New Uzbekistan" Development

Strategy for 2022-2026. A strategic framework was synthesized based on these data sources to

identify key intervention areas for a national program. Results: The analysis identified two core

strategic pillars for a comprehensive national program: (1) Primary Prevention and (2) Early

Detection and Management. The Primary Prevention pillar encompasses three key domains:

strengthening environmental controls to reduce exposure to pollutants and allergens; launching

national public health campaigns to improve health literacy regarding asthma risk factors; and

promoting healthy nutrition, including breastfeeding. The Early Detection pillar focuses on four

critical areas: enhancing the capacity of primary healthcare professionals through continuous

medical education; expanding access to objective diagnostic tools like spirometry in primary

care settings; implementing a national screening program for high-risk children; and integrating

digital health technologies and clinical decision support systems to standardize care. Conclusion:

A comprehensive, government-led national program is critical to fundamentally improving

childhood asthma outcomes in Uzbekistan. Such a program, built on the pillars of robust primary

prevention and systematic early detection, has the potential to reduce the incidence and severity

of the disease, decrease long-term healthcare costs, and improve the quality of life for millions of

children. Successful implementation will require strong political commitment, multi-sectoral

collaboration, and sustained financial investment.

Keywords:

bronchial asthma, children, state program, healthcare policy, prevention, early

diagnosis, Uzbekistan, primary healthcare.

АННОТАЦИЯ:

Введение: Бронхиальная астма у детей представляет собой серьезную и

растущую проблему общественного здравоохранения в Узбекистане, приводящую к

значительной заболеваемости и социально-экономическому бремени. Задержки в

диагностике и неоптимальные стратегии профилактики на уровне первичного звена

здравоохранения усугубляют проблему. Для эффективного долгосрочного контроля


background image

INTERNATIONAL JOURNAL

OF MEDICAL SCIENCES

ISSN NUMBER: 2692 - 5206

Volume 5,September ,2025

51

необходим скоординированный стратегический подход на государственном уровне. В

данной статье анализируется стратегическое значение национальных программ по

профилактике и раннему выявлению детской астмы в Узбекистане. Методы: В данном

исследовании используется методология анализа политики здравоохранения. Она

включает систематический обзор международных руководств Всемирной организации

здравоохранения (ВОЗ) и Глобальной инициативы по астме (GINA), анализ успешных

национальных программ по борьбе с астмой в других странах, а также изучение текущих

приоритетов здравоохранения Узбекистана, изложенных в Стратегии развития «Новый

Узбекистан» на 2022-2026 годы. На основе этих источников данных были синтезированы

стратегические рамки для определения ключевых направлений для национальной

программы. Результаты: Анализ определил два основных стратегических направления для

комплексной национальной программы: (1) Первичная профилактика и (2) Раннее

выявление и ведение. Направление первичной профилактики включает три ключевые

области: усиление экологического контроля для снижения воздействия загрязнителей и

аллергенов; запуск национальных кампаний по повышению медицинской грамотности

населения в отношении факторов риска астмы; и продвижение здорового питания,

включая грудное вскармливание. Направление раннего выявления сосредоточено на

четырех критически важных областях: повышение потенциала специалистов первичного

звена здравоохранения через непрерывное медицинское образование; расширение доступа

к объективным диагностическим инструментам, таким как спирометрия, в учреждениях

первичной медико-санитарной помощи; внедрение национальной программы скрининга

для детей из групп высокого риска; и интеграция цифровых технологий здравоохранения

и систем поддержки принятия клинических решений для стандартизации помощи.

Заключение: Комплексная национальная программа под руководством правительства

имеет решающее значение для коренного улучшения исходов детской астмы в

Узбекистане. Такая программа, основанная на принципах надежной первичной

профилактики и систематического раннего выявления, способна снизить заболеваемость и

тяжесть течения болезни, сократить долгосрочные расходы на здравоохранение и

улучшить качество жизни миллионов детей. Успешная реализация потребует сильной

политической воли, межсекторального сотрудничества и устойчивых финансовых

инвестиций.

Ключевые слова:

бронхиальная астма, дети, государственная программа, политика

здравоохранения,

профилактика,

ранняя

диагностика,

Узбекистан,

первичное

здравоохранение.

INTRODUCTION

Bronchial asthma is the most common chronic disease of childhood, affecting an

estimated 14% of children globally and posing a significant public health challenge worldwide

(Global Asthma Network, 2020). The burden of asthma is not limited to its clinical

manifestations, such as recurrent wheezing, coughing, and dyspnea; it extends to a diminished

quality of life, school absenteeism, frequent emergency department visits, and a substantial

economic strain on families and healthcare systems (Asher et al., 2006). While there is no cure

for asthma, effective management centered on prevention and early, accurate diagnosis can

control the disease, reduce morbidity, and prevent long-term airway damage.


background image

INTERNATIONAL JOURNAL

OF MEDICAL SCIENCES

ISSN NUMBER: 2692 - 5206

Volume 5,September ,2025

52

In Uzbekistan, as in many developing nations undergoing rapid industrialization and

urbanization, the prevalence of allergic diseases, including bronchial asthma, is on the rise. The

nation's "New Uzbekistan" Development Strategy for 2022-2026 identifies the protection of

public health, especially maternal and child health, as a paramount priority (Decree of the

President of the Republic of Uzbekistan, No. PF-60, 2022). However, the primary healthcare

system, which is the first point of contact for children with respiratory symptoms, faces

significant challenges in managing childhood asthma effectively. Clinical studies, including

those conducted within the region, consistently point to a significant delay between the onset of

symptoms and a formal diagnosis, often by several years. This delay is largely attributed to the

misinterpretation of asthma symptoms as recurrent "obstructive bronchitis," limited access to

objective diagnostic tools, and a lack of standardized clinical pathways in primary care.

This diagnostic and therapeutic gap leads to uncontrolled asthma, increased severity,

and the overuse of inappropriate medications like antibiotics, while delaying essential anti-

inflammatory therapy. Consequently, many children progress to more severe forms of the

disease, leading to preventable hospitalizations and long-term complications. Addressing this

multifaceted problem requires moving beyond individual clinical improvements to a systematic,

top-down approach coordinated at the national level. A comprehensive state program dedicated

to asthma prevention and early detection can create the necessary infrastructure, policies, and

educational framework to drive meaningful and sustainable change.

This article, therefore, aims to provide a comprehensive analysis of the strategic

importance and essential components of a national program for the prevention and early

detection of childhood bronchial asthma in Uzbekistan. It proposes a strategic framework based

on international best practices and tailored to the local healthcare context, arguing that such a

program is a critical investment in the nation's future health and well-being.

METHODS

This study utilizes a health policy analysis and strategic framework development

methodology. The approach is qualitative and synthetic, drawing upon multiple sources to

construct a comprehensive model for a national asthma program in Uzbekistan. The

methodological process consisted of three distinct stages:

Scoping review of international guidelines and literature: A scoping review was

conducted to identify best practices and evidence-based recommendations for the prevention and

management of childhood asthma. Key sources included official publications and strategic

documents from leading international health organizations, primarily the World Health

Organization (WHO) and the Global Initiative for Asthma (GINA). The review focused on

identifying core components of successful national asthma strategies, including public health

interventions, clinical care standards, and health system requirements. Furthermore, a search of

academic databases (PubMed, Scopus) was performed to identify case studies and evaluations of

national asthma programs implemented in other countries with similar socio-economic or

healthcare system characteristics.

Contextual analysis of the national healthcare landscape: The recommendations derived

from the international review were contextualized by analyzing the current state of Uzbekistan's

healthcare system and policy environment. The primary document for this analysis was the "New

Uzbekistan" Development Strategy for 2022-2026, which outlines national priorities, including

the strengthening of primary healthcare, the digitalization of the health sector, and the focus on

preventive medicine. Local pediatric and allergology textbooks and national clinical protocols

were also reviewed to understand the existing diagnostic and therapeutic paradigms within the


background image

INTERNATIONAL JOURNAL

OF MEDICAL SCIENCES

ISSN NUMBER: 2692 - 5206

Volume 5,September ,2025

53

country. This stage aimed to ensure that the proposed framework is not only evidence-based but

also politically relevant and feasible within the Uzbek context.

Synthesis of a strategic framework: The final stage involved synthesizing the findings

from the literature review and the contextual analysis into a coherent strategic framework. The

IMRAD structure was adapted for this purpose, where the "Results" section presents the

synthesized framework itself, outlining the core pillars, strategic objectives, and key

interventions. This framework was designed to be a practical and actionable model for

policymakers, public health officials, and clinical leaders. The framework's components were

categorized into two main pillars—Primary Prevention and Early Detection—to align with a

comprehensive public health approach that addresses the entire disease continuum.

RESULTS

The analysis culminates in a proposed two-pillar strategic framework for a national

program aimed at reducing the burden of childhood bronchial asthma in Uzbekistan.

Pillar I: Primary prevention – reducing the incidence of asthma.

The objective of this pillar is to mitigate exposure to modifiable risk factors known to

contribute to the development of asthma in genetically susceptible children. This requires a

multi-sectoral approach extending beyond the healthcare system.

Strategic Objective 1.1: Strengthening Environmental Controls. This involves

developing and enforcing stricter national air quality standards, particularly for industrial

emissions and vehicle exhaust (PM2.5, SO2, NOx). A national program should advocate for

urban planning policies that promote green spaces, reduce traffic congestion in residential areas,

and support the transition to cleaner energy sources. At a micro-level, it includes public

awareness campaigns on reducing indoor allergens (dust mites, mold, pet dander) and

eliminating indoor tobacco smoke exposure.

Strategic Objective 1.2: Enhancing Public Health Literacy. A sustained, nationwide

media campaign is required to educate the public, especially prospective parents and young

families, about the primary risk factors for asthma. Key messages should focus on the benefits of

maternal health during pregnancy, the risks of smoking, the importance of exclusive

breastfeeding for the first six months of life (which has been shown to have a protective effect),

and the signs of early allergic disease. Materials should be culturally appropriate and

disseminated through various channels, including television, social media, and primary

healthcare clinics.

Strategic Objective 1.3: Promoting Healthy Nutrition. The state program should

integrate with national nutrition policies to promote a diet rich in antioxidants (fruits, vegetables)

and omega-3 fatty acids, which may have a protective role against allergic sensitization. This

includes regulating the marketing of processed foods with high levels of artificial additives to

children and supporting policies that make healthy food choices more accessible and affordable.

Pillar II: Early detection and management – improving health outcomes.

The objective of this pillar is to reduce the time from symptom onset to diagnosis and to

ensure that all children receive timely, evidence-based care. This focuses on strengthening the

primary healthcare system.

Strategic Objective 2.1: Capacity Building for Primary Healthcare Professionals. A

national, standardized continuous medical education (CME) curriculum on pediatric asthma

should be developed and mandated for all primary care pediatricians and general practitioners.

This curriculum must focus on differentiating asthma from other respiratory conditions,

recognizing early warning signs, understanding asthma phenotypes, and utilizing predictive risk


background image

INTERNATIONAL JOURNAL

OF MEDICAL SCIENCES

ISSN NUMBER: 2692 - 5206

Volume 5,September ,2025

54

indices (e.g., the Asthma Predictive Index - API). Training should move beyond theory to

include practical skills in patient communication and management.

Strategic Objective 2.2: Expanding Access to Objective Diagnostics. A state program

must include a phased plan for equipping primary care clinics, particularly in rural areas, with

essential diagnostic tools. This includes the widespread provision of peak flow meters and,

crucially, spirometers suitable for pediatric use. The program must also fund the training of

nurses and doctors in performing and interpreting these tests, ensuring that objective lung

function measurement becomes a routine part of the diagnostic process for children over five.

Strategic Objective 2.3: Implementing a National Screening Program for High-Risk

Infants. A formal screening protocol should be integrated into the routine well-child visit

schedule. This protocol would use a simple checklist to identify high-risk infants (e.g., those

with a parental history of asthma, personal history of atopic dermatitis, or recurrent wheezing

episodes). Children identified as high-risk would be flagged for more intensive follow-up and

priority referral to a specialist (allergist or pulmonologist).

Strategic Objective 2.4: Integrating Digital Health Technologies. The program should

support the development and implementation of a national electronic health record (EHR)

system that includes a dedicated asthma module. This module can embed a clinical decision

support system (CDSS) that prompts physicians with diagnostic criteria, risk factor checklists,

and guideline-recommended treatment options. Furthermore, mobile health (mHealth)

applications could be developed for parents to track symptoms, medication use, and PEF

readings, with data integrated into the EHR to facilitate better disease monitoring.

DISCUSSION

The proposed two-pillar framework presents a comprehensive, top-down strategy to

fundamentally address the challenge of childhood asthma in Uzbekistan. The significance of

such a state-led program lies in its ability to create systemic change that is beyond the reach of

individual clinicians or institutions. By simultaneously targeting primary prevention and

strengthening early detection, the program addresses the root causes of the asthma burden and

creates a more resilient and responsive healthcare system.

The emphasis on primary prevention, particularly environmental controls and public

health education, represents a long-term investment in the nation's health. While the clinical

impact of such measures may take years to become fully apparent, they hold the potential to

bend the curve of rising asthma prevalence. This requires strong inter-sectoral collaboration

between the Ministry of Health, the Ministry of Ecology, the Ministry of Education, and urban

planning authorities. The main challenge in this domain is securing the political will and long-

term funding required for large-scale infrastructure and policy changes.

The second pillar, focused on early detection at the primary care level, offers more

immediate returns. Empowering primary care physicians with knowledge, tools, and clear

clinical pathways is the single most effective way to close the existing diagnostic gap. The

success of this pillar hinges on a commitment to continuous education and overcoming logistical

hurdles in equipment procurement and distribution. The integration of digital health tools is not

merely a modernization effort; it is a critical tool for standardization and quality control. A

CDSS can ensure that every child, whether in a large city or a remote village, is assessed

according to the same evidence-based criteria, thereby reducing diagnostic variability and

improving equity of care.

Implementing this comprehensive framework is not without its challenges. The primary

barrier will likely be financial. A national asthma program requires a significant and sustained


background image

INTERNATIONAL JOURNAL

OF MEDICAL SCIENCES

ISSN NUMBER: 2692 - 5206

Volume 5,September ,2025

55

budget for training, equipment, public campaigns, and digital infrastructure. Therefore, a robust

economic evaluation demonstrating the long-term cost-effectiveness of the program—by

calculating the savings from reduced hospitalizations, emergency visits, and medication costs—

is a prerequisite for securing government funding. Another challenge is overcoming clinical

inertia and resistance to change among healthcare providers. Mandating new protocols and

digital tools requires a thoughtful change management strategy, including clinician champions,

ongoing support, and clear communication about the benefits for both patients and providers.

In conclusion, while individual components of this framework may already exist in

some form, their integration into a single, cohesive, and government-endorsed national program

is what will catalyze transformative change. It provides a clear roadmap for policymakers and

stakeholders to work collaboratively towards a future where every child with asthma in

Uzbekistan has the opportunity to breathe freely and live a full, healthy life.

CONCLUSION

Childhood bronchial asthma is a pressing public health issue in Uzbekistan that

demands a strategic, proactive, and comprehensive response. The current system, characterized

by diagnostic delays and a reactive approach to care, results in preventable morbidity and places

a heavy burden on children, families, and the healthcare system. This article has outlined a

strategic framework for a national program designed to address these shortcomings through two

synergistic pillars: robust primary prevention and systematic early detection and management.

By investing in environmental health, public education, and strengthening the capacity

of the primary healthcare system with modern tools and knowledge, Uzbekistan can significantly

reduce the incidence and severity of childhood asthma. The implementation of such a program is

not merely a healthcare objective but a strategic investment in the nation's human capital. It

requires strong political leadership, multi-sectoral collaboration, and a long-term financial

commitment. The path forward is challenging, but the potential rewards—healthier children,

stronger families, and a more efficient healthcare system—are immeasurable.

References:

1.

Asher, M. I., Montefort, S., Björkstén, B., Lai, C. K., Strachan, D. P., Weiland, S. K., &

Williams, H. (2006). Worldwide time trends in the prevalence of symptoms of asthma,

allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat

multicountry

cross-sectional

surveys.

The

Lancet,

368(9537),

733-743.

https://doi.org/10.1016/S0140-6736(06)69283-0

2.

Decree of the President of the Republic of Uzbekistan. (2022, January 28). On the

Development Strategy of the New Uzbekistan for 2022-2026 (No. PF-60). National

Database of Legislation of the Republic of Uzbekistan.

3.

Global Asthma Network. (2020). The Global Asthma Report 2020. Auckland, New Zealand.

4.

Global Initiative for Asthma. (2023). Global Strategy for Asthma Management and

Prevention. GINA Reports. Retrieved from https://ginasthma.org/

5.

Martinez, F. D. (2019). The origins of asthma and allergic diseases. The Journal of Allergy

and

Clinical

Immunology:

In

Practice,

7(3),

799-805.

https://www.google.com/search?q=https://doi.org/10.1016/j.jaip.2019.01.039

6.

Ministry of Health of the Republic of Uzbekistan. (2021). National Clinical Protocols for the

Diagnosis and Treatment of Diseases in Children. Tashkent: "Ibn Sino".


background image

INTERNATIONAL JOURNAL

OF MEDICAL SCIENCES

ISSN NUMBER: 2692 - 5206

Volume 5,September ,2025

56

7.

Nurmatov, U. B., van Schayck, C. P., Hurwitz, B., & Sheikh, A. (2012). House dust mite

avoidance measures for perennial allergic rhinitis: an updated Cochrane systematic review.

Allergy, 67(2), 158-165. https://www.google.com/search?q=https://doi.org/10.1111/j.1398-

9995.2011.02755.x

8.

Papadopoulos, N. G., Arakawa, H., Carlsen, K. H., Custovic, A., Gern, J., Lemanske, R., ...

& Wahn, U. (2020). International consensus on (ICON) pediatric asthma. Allergy, 75(8),

1913-1931. https://doi.org/10.1111/all.14251

9.

World Health Organization. (2021). Noncommunicable diseases: Childhood asthma. WHO

Fact Sheets. Retrieved from https://www.who.int/news-room/fact-sheets/detail/asthma

10.

Yusupalieva, D., & Zuparova, M. (2018). The prevalence and risk factors of bronchial

asthma among children in the Fergana Valley. Journal of Theoretical and Clinical Medicine,

(4), 56-60.

References

Asher, M. I., Montefort, S., Björkstén, B., Lai, C. K., Strachan, D. P., Weiland, S. K., & Williams, H. (2006). Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. The Lancet, 368(9537), 733-743. https://doi.org/10.1016/S0140-6736(06)69283-0

Decree of the President of the Republic of Uzbekistan. (2022, January 28). On the Development Strategy of the New Uzbekistan for 2022-2026 (No. PF-60). National Database of Legislation of the Republic of Uzbekistan.

Global Asthma Network. (2020). The Global Asthma Report 2020. Auckland, New Zealand.

Global Initiative for Asthma. (2023). Global Strategy for Asthma Management and Prevention. GINA Reports. Retrieved from https://ginasthma.org/

Martinez, F. D. (2019). The origins of asthma and allergic diseases. The Journal of Allergy and Clinical Immunology: In Practice, 7(3), 799-805. https://www.google.com/search?q=https://doi.org/10.1016/j.jaip.2019.01.039

Ministry of Health of the Republic of Uzbekistan. (2021). National Clinical Protocols for the Diagnosis and Treatment of Diseases in Children. Tashkent: "Ibn Sino".

Nurmatov, U. B., van Schayck, C. P., Hurwitz, B., & Sheikh, A. (2012). House dust mite avoidance measures for perennial allergic rhinitis: an updated Cochrane systematic review. Allergy, 67(2), 158-165. https://www.google.com/search?q=https://doi.org/10.1111/j.1398-9995.2011.02755.x

Papadopoulos, N. G., Arakawa, H., Carlsen, K. H., Custovic, A., Gern, J., Lemanske, R., ... & Wahn, U. (2020). International consensus on (ICON) pediatric asthma. Allergy, 75(8), 1913-1931. https://doi.org/10.1111/all.14251

World Health Organization. (2021). Noncommunicable diseases: Childhood asthma. WHO Fact Sheets. Retrieved from https://www.who.int/news-room/fact-sheets/detail/asthma

Yusupalieva, D., & Zuparova, M. (2018). The prevalence and risk factors of bronchial asthma among children in the Fergana Valley. Journal of Theoretical and Clinical Medicine, (4), 56-60.